Related references
Note: Only part of the references are listed.Novel Endochin-Like Quinolones Exhibit Potent In Vitro Activity against Plasmodium knowlesi but Do Not Synergize with Proguanil
Donelly A. van Schalkwyk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Naturally Acquired Human Plasmodium cynomolgi and P. knowlesi Infections, Malaysian Borneo
Thamayanthi Nada Raja et al.
EMERGING INFECTIOUS DISEASES (2020)
Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum
Donelly A. van Schalkwyk et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2019)
Enhanced Ex Vivo Plasmodium vivax Intraerythrocytic Enrichment and Maturation for Rapid and Sensitive Parasite Growth Assays
Gabriel W. Rangel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Alejandro Llanos-Cuentas et al.
LANCET INFECTIOUS DISEASES (2018)
Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents
Donelly A. van Schalkwyk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia
Suwanna Chaorattanakawee et al.
MALARIA JOURNAL (2017)
Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal
Aminata Mbaye et al.
MALARIA JOURNAL (2017)
Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution
Gavin G. Rutledge et al.
NATURE (2017)
Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest in Rio de Janeiro: a molecular epidemiological investigation
Patricia Brasil et al.
LANCET GLOBAL HEALTH (2017)
Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites
Megan S. J. Arnold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria
Margaret A. Phillips et al.
ACS INFECTIOUS DISEASES (2016)
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Margaret A. Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Natural infection of Plasmodium brasilianum in humans: Man and monkey share quartan malaria parasites in the Venezuelan Amazon
Albert Lalremruata et al.
EBIOMEDICINE (2015)
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Kelli L. Kuhen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Human red blood cell-adapted Plasmodium knowlesi parasites: a new model system for malaria research
Christof Gruering et al.
CELLULAR MICROBIOLOGY (2014)
First case of a naturally acquired human infection with Plasmodium cynomolgi
Thuy H. Ta et al.
MALARIA JOURNAL (2014)
Susceptibility of human Plasmodium knowlesi infections to anti-malarials
Farrah A. Fatih et al.
MALARIA JOURNAL (2013)
Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers
Donelly A. van Schalkwyk et al.
MALARIA JOURNAL (2013)
Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes
Robert W. Moon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humans
Caeul Lim et al.
NATURE COMMUNICATIONS (2013)
Human ex vivo studies on asexual Plasmodium vivax: The best way forward
Bruce Russell et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2012)
The Presence of Leukocytes in Ex Vivo Assays Significantly Increases the 50-Percent Inhibitory Concentrations of Artesunate and Chloroquine against Plasmodium vivax and Plasmodium falciparum
S. Kaewpongsri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communities
Mary Chiaka Oguike et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2011)
The Human Serum Metabolome
Nikolaos Psychogios et al.
PLOS ONE (2011)
Two Nonrecombining Sympatric Forms of the Human Malaria Parasite Plasmodium ovale Occur Globally
Colin J. Sutherland et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Thousands of chemical starting points for antimalarial lead identification
Francisco-Javier Gamo et al.
NATURE (2010)
Chemical genetics of Plasmodium falciparum
W. Armand Guiguemde et al.
NATURE (2010)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
Plasmodium vivax trophozoites insensitive to chloroquine
Wesley W. Sharrock et al.
MALARIA JOURNAL (2008)
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
David Plouffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis
Colin J. Sutherland et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
A large focus of naturally acquired Plasmodium knowlesi infections in human beings
B Singh et al.
LANCET (2004)
Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P-vivax is endemic
BM Russell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Ex-vivo short-term culture and developmental assessment of Plasmodium vivax
K Chotivanich et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Share Paper
